The use of GLP‐1 receptor agonists in hospitalised patients: An untapped potential

In the outpatient setting, glucagon‐like peptide‐1 (GLP‐1) receptor agonists have proved to be highly efficacious drugs that provide glycaemic control with a low risk of hypoglycaemia. These characteristics make GLP‐1 receptor agonists attractive agents to treat dysglycaemia in perioperative or high...

Descripción completa

Detalles Bibliográficos
Autores principales: Mustafa, Omar G., Whyte, Martin B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899667/
https://www.ncbi.nlm.nih.gov/pubmed/31141838
http://dx.doi.org/10.1002/dmrr.3191

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899667/
https://www.ncbi.nlm.nih.gov/pubmed/31141838
http://dx.doi.org/10.1002/dmrr.3191

Ejemplares similares